Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 May 1;169(5):1655-68.
doi: 10.1084/jem.169.5.1655.

I-A alpha polymorphic residues that determine alloreactive T cell recognition

Affiliations

I-A alpha polymorphic residues that determine alloreactive T cell recognition

M Pierres et al. J Exp Med. .

Abstract

An individual's T lymphocytes are highly reactive to allogeneic MHC molecules. As a step in deciphering the mechanism of allorecognition by T lymphocytes, we have attempted to identify the TCR's target on MHC class II molecules, in particular the polymorphic residues that determine the specificity of recognition. We have generated a panel of Ak-reactive, Ab-nonreactive T cell hybridomas, and sets of L cell transfectants displaying A alpha A beta molecules with wild-type, chimeric or single site-mutated A alpha chains, with reciprocal interchanges between Ak and Ab. We then measured the stimulation of the T hybridomas in response to the transfectants. The results indicate that the hybridomas recognize diverse and complex determinants, with contributions from both A alpha and A beta chains, and from several regions or amino acids of the A alpha chain. The data are most consistent with a model in which alloreactivity results from the presentation of peptides to the T cell by an allogeneic MHC molecule, peptides that cannot be presented by the responder's own MHC complexes. The specificity of allorecognition seems to be imparted mainly by peptide/MHC molecule rather than TCR/MHC molecule contacts.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cell Immunol. 1977 Mar 1;29(1):1-5 - PubMed
    1. Nature. 1986 Dec 11-17;324(6097):578-9 - PubMed
    1. Eur J Immunol. 1980 Dec;10(12):950-7 - PubMed
    1. Science. 1981 Jul 10;213(4504):172-8 - PubMed
    1. Nature. 1987 Feb 12-18;325(6105):625-8 - PubMed

Publication types